Literature DB >> 19695901

Effects of hepatic artery chemoembolization using cisplatin-lipiodol suspension with gelatin sponge particles on swine liver.

Shinya Sahara1, Hirohiko Tanihata, Morio Sato, Nobuyuki Kawai, Isao Takasaka, Hiroyuki Minamiguchi, Motoki Nakai, Tetsuo Sonomura.   

Abstract

PURPOSE: To define the effects of hepatic artery chemoembolization with cisplatin-lipiodol suspension and gelatin sponge particles on swine liver tissue and estimate the concentration of cisplatin that would have a minimal negative effect on normal liver parenchyma.
MATERIALS AND METHODS: Twelve pigs were divided into four groups: group A was the control group in which hepatic arteries were embolized with lipiodol and gelatin sponge particle (n = 3); group B animals were embolized with 10 mg/mL cisplatin-lipiodol suspension plus gelatin sponge particle (n = 3), group C with 20 mg/mL cisplatin-lipiodol suspension plus gelatin sponge particle (n = 3), and group D with 30 mg/mL cisplatin-lipiodol suspension plus gelatin sponge particle (n = 3). Pigs were euthanized 1 week after embolization, and the resected livers were cut into 10-mm-thick sections. The livers and necrotic foci were contoured in each section, and the necrosis volume ratio was calculated.
RESULTS: The necrosis volume ratios of the livers in groups A, B, C, and D were 0.832% +/- 0.334, 2.324% +/- 1.126, 8.056% +/- 3.276, and 11.82% +/- 4.921, respectively. Significant differences (P < .05) in necrosis volume ratio were found between groups A and C, groups A and D, groups B and C, and groups B and D; no significant difference was found between groups A and B.
CONCLUSIONS: Hepatic artery chemoembolization with higher doses of cisplatin causes greater damage to liver tissue; 10 mg/mL cisplatin-lipiodol suspension causes minimal damage, similar to that without cisplatin, and is related to minimal negative changes in a swine model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19695901     DOI: 10.1016/j.jvir.2009.06.028

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  4 in total

1.  Effect of interval between transcatheter hepatic arterial embolization and radiofrequency ablation on ablated lesion size in a swine model.

Authors:  Cao Guang; Nobuyuki Kawai; Morio Sato; Isao Takasaka; Hiroki Minamiguchi; Shinya Sahara; Kouhei Nakata; Tetsuo Sonomura; Shintaro Shirai; Ichiro Mori; Renjie Yang
Journal:  Jpn J Radiol       Date:  2011-09-29       Impact factor: 2.374

2.  Prospective comparison of transcatheter arterial chemoembolization with Lipiodol-epirubicin and Lipiodol-cisplatin for treatment of recurrent hepatocellular carcinoma.

Authors:  Shinya Sahara; Nobuyuki Kawai; Morio Sato; Hiroki Minamiguchi; Motoki Nakai; Isao Takasaka; Kouhei Nakata; Akira Ikoma; Naohisa Sawa; Tetsuo Sonomura; Shintaro Shirai
Journal:  Jpn J Radiol       Date:  2010-06-30       Impact factor: 2.374

3.  Future perspectives on the treatment of hepatocellular carcinoma with cisplatin.

Authors:  Toru Ishikawa
Journal:  World J Hepatol       Date:  2009-10-31

Review 4.  Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques.

Authors:  Norihiro Imai; Masatoshi Ishigami; Yoji Ishizu; Teiji Kuzuya; Takashi Honda; Kazuhiko Hayashi; Yoshiki Hirooka; Hidemi Goto
Journal:  World J Hepatol       Date:  2014-12-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.